Navigation Links
Intrinsic Clinical Systems to Attend DIA Annual Meeting in Chicago, Illinois
Date:6/19/2017

Intrinsic Clinical Systems announced it will attend DIA’s Annual Meeting, designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies.Intrinsic will be discussing its mission to make clinical trial management faster, easier, and less painful. Attendees can visit Intrinsic’s booth showcasing its four key clinical software products—CTMS, eTMF, resource management, and feasibility/site engagement—that help biopharma companies more easily manage their operations.

“We’ve felt the frustration of clinical trial management systems that are overstuffed with needless features,” said Greg Cohee, Partner at Intrinsic Clinical Systems. “We spent a lot of time getting the user experience right. We’ve heard the industry’s requests for minimal data entry, a simple interface, and a foolproof study management solution.”

Intrinsic CTMS is a contemporary CTMS with a streamlined interface that integrates with nearly any other clinical system,” said Eric Lake, Partner at Intrinsic Clinical Systems. “The tool’s clean design was created to make study management seamless and efficient. The modern, ribbon-based navigation reduces the learning curve to almost nothing.”

“In addition, we are thrilled to share our resource management tool, Insights RM, with DIA attendees. We’ve really had an overwhelming response thus far,” continued Eric Lake. “The tool resonates with companies because of its simple and flexible structure. It can be customized easily to fit the needs of any organization, which allows for convenient, time efficient, and cost effective management and manipulation of data and reports.”

“The pharma industry is facing new challenges in study complexity which makes this a pivotal time for more efficient tools. Intrinsic CTMS, Intrinsic eTMF, and Insights RM are made for proactive study management and data integration while abandoning all the “extras” that people never use,” said Matt Kiernan, Partner at Intrinsic Clinical Systems. “We’re also excited to showcase Informer, our site feasibility and engagement tool, which lets sponsors easily collect feasibility survey results while at the same time keeping track of who is contacting which sites. Companies are focusing on improving site relationships, and Informer is built for that purpose.”

Those interested in learning more about Intrinsic Clinical Systems or upcoming events can visit http://www.IntrinsicCS.com. To request additional information, please contact Eric Lake at (973) 945-4482.

About Intrinsic Clinical Systems:
The Intrinsic Clinical Systems mission is to provide elegant, streamlined tools to simplify all aspects of drug development operations so biopharma companies can thrive in today’s competitive and cost-conscious environment. By building software tools that provide high value without multi-million dollar price tags, Intrinsic products let companies large and small manage and simplify operations by leveraging new technologies.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14437933.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Intrinsic Imaging Awarded Medical Device Trial for Percutaneous Tumor Ablation
2. Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight
3. New Intrinsically Safe XPP-5454GC LED Headlamp from Nightstick® Now Clips Direct to Hard Hats
4. Intrinsic Clinical Systems Unveils a New Kind of Clinical Trial Management System
5. Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer
6. Kidney Week 2013: New innovations in clinical science
7. Salar Joins Medical Informatics Experts to Judge AMIA’s First Ever Student Design Challenge: Reinventing Clinical Documentation
8. The DelRay Recovery Center Appoints Britt Bonner as the Director of Clinical Outreach
9. Clinical trial looks at impact of platelet-rich plasma therapy on tennis elbow
10. Nemours receives Dept. of Defense award to study physicians maintenance of optimal clinical program
11. Clinical trial finds concurrent therapy not necessary to achieve high pathological in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at ... , Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with website ... Awards to be consumer voted. The Magic Wand Rechargeable won in stiff competition ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical Quality ... Consulting **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , Early ... FDA scrutiny and growing demands to track and report adverse events place even ...
(Date:7/24/2017)... Island (PRWEB) , ... July 24, 2017 , ... ... a new office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The ... Jordan Fabrikant, M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. ...
(Date:7/24/2017)... ... ... “A Short Walk to the Mailbox”: a remarkable memoir of an unconventional ... Ed Clark. Ed Clark is a church music director and choral conductor. ... music and worship leader for over fifty years. He has a master’s degree ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. ... will release its second quarter 2017 operating results on ... conference call to follow at 5:00 p.m. ET. ... may listen to a live broadcast of the conference ... and referencing participant code 51641230 approximately 15 minutes prior ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
Breaking Medicine Technology: